Table 2

Comparison of serum proteomic tests and validation status

HICPIRPerspectIV
Components in signature (n, type)8 spectral features11 274 spectral features16 8 glycoproteins17
Date first published* or presented**2007*11 2018**43 2019**17
Designed for immunotherapy?No11 Yes16 Yes17
Test locked?CompletedCompletedPending
Independent cohort validation?Completed21 Completed38 Pending
Prospective clinical validation?Completed20 PendingPending
  • HIC, host immune classifier; PIR, primary immune response.